1. Home
  2. KRYS vs LOPE Comparison

KRYS vs LOPE Comparison

Compare KRYS & LOPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • LOPE
  • Stock Information
  • Founded
  • KRYS 2015
  • LOPE 1949
  • Country
  • KRYS United States
  • LOPE United States
  • Employees
  • KRYS N/A
  • LOPE N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • LOPE Other Consumer Services
  • Sector
  • KRYS Health Care
  • LOPE Real Estate
  • Exchange
  • KRYS Nasdaq
  • LOPE Nasdaq
  • Market Cap
  • KRYS 4.6B
  • LOPE 4.7B
  • IPO Year
  • KRYS 2017
  • LOPE 2008
  • Fundamental
  • Price
  • KRYS $187.96
  • LOPE $181.70
  • Analyst Decision
  • KRYS Strong Buy
  • LOPE Buy
  • Analyst Count
  • KRYS 7
  • LOPE 3
  • Target Price
  • KRYS $210.00
  • LOPE $197.67
  • AVG Volume (30 Days)
  • KRYS 245.3K
  • LOPE 161.9K
  • Earning Date
  • KRYS 02-19-2025
  • LOPE 02-19-2025
  • Dividend Yield
  • KRYS N/A
  • LOPE N/A
  • EPS Growth
  • KRYS 669.23
  • LOPE 13.68
  • EPS
  • KRYS 3.00
  • LOPE 7.73
  • Revenue
  • KRYS $290,515,000.00
  • LOPE $1,033,002,000.00
  • Revenue This Year
  • KRYS $483.09
  • LOPE $9.38
  • Revenue Next Year
  • KRYS $57.70
  • LOPE $6.18
  • P/E Ratio
  • KRYS $62.62
  • LOPE $23.72
  • Revenue Growth
  • KRYS 473.02
  • LOPE 7.50
  • 52 Week Low
  • KRYS $109.57
  • LOPE $126.17
  • 52 Week High
  • KRYS $219.34
  • LOPE $192.18
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 73.39
  • LOPE 59.39
  • Support Level
  • KRYS $148.00
  • LOPE $180.14
  • Resistance Level
  • KRYS $190.00
  • LOPE $192.18
  • Average True Range (ATR)
  • KRYS 7.31
  • LOPE 3.65
  • MACD
  • KRYS 3.66
  • LOPE -0.03
  • Stochastic Oscillator
  • KRYS 93.87
  • LOPE 47.60

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About LOPE Grand Canyon Education Inc.

Grand Canyon Education Inc is a publicly traded education services company dedicated to serving colleges and universities. GCE's university partner is Grand Canyon University, an Arizona non-profit corporation that operates a comprehensive regionally accredited university that offers graduate and undergraduate degree programs, emphases and certificates across nine colleges both online, on ground at its campus in Phoenix, Arizona and at four off-site classroom and laboratory sites. The Company generates all of its revenue through services agreements with its university partners.

Share on Social Networks: